Prot #TBI-01:A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients with Chronic Motor Deficit from Traumatic Brain Injury (TBI)

Project: Research project

Project Details

StatusFinished
Effective start/end date3/14/17 → 10/31/19

Funding

  • INC Research, LLC (Prot #TBI-01 // Prot #TBI-01)
  • SanBio, Inc. (Prot #TBI-01 // Prot #TBI-01)